Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registries

Department of internal medicine, referral center for autoimmune cytopenias in adults, and Clinical investigation center 1436, Toulouse University hospital, Toulouse, France; European Research Consortium on Immune thrombocytopenia (ERCI), founding member
ITP Centre and UK Adult ITP registry, Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom and Queen Mary University of London, London
Department of Hematology, San Bortolo Hospital, Vicenza
European Research Consortium on Immune thrombocytopenia (ERCI), founding member; Østfold hospital, Norway and Institute of clinical medicine, University of Oslo, Oslo
Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der Technischen Universität, Dresden
Universitätsklinikum Jena, Jena
Department of Hematology/Oncology, University Children’s Hospital Basel, Basel
ITP Centre and UK Adult ITP registry, Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom and Queen Mary University of London, London
Department of internal medicine, referral center for autoimmune cytopenias in adults, and Clinical investigation center 1436, Toulouse University hospital, Toulouse
Hematology Project Foundation, Affiliated to the Department of Hematology, San Bortolo Hospital, Vicenza
Østfold hospital, Norway and Institute of clinical medicine, University of Oslo, Oslo
Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der Technischen Universität, Dresden
Guy’s Hospital, London
European Research Consortium on Immune thrombocytopenia (ERCI), founding member; DSM, Università degli Studi di Trieste, Trieste
Østfold hospital, Norway and Institute of clinical medicine, University of Oslo, Oslo
European Research Consortium on Immune thrombocytopenia (ERCI), founding member; Department of Hematology/Oncology, University Children’s Hospital Basel, Basel
European Research Consortium on Immune thrombocytopenia (ERCI), founding member; Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, Murcia, Spain
European Research Consortium on Immune thrombocytopenia (ERCI), founding member; Hospital Universitario de Burgos, Burgos, Spain
European Research Consortium on Immune thrombocytopenia (ERCI), founding member; ITP Centre and UK Adult ITP registry, Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom and Queen Mary University of London, London
European Research Consortium on Immune thrombocytopenia (ERCI), founding member; Mondor University Hospital, Créteil
European Research Consortium on Immune thrombocytopenia (ERCI), founding member; Imperial College London, London
European Research Consortium on Immune thrombocytopenia (ERCI), founding member; Hematology Project Foundation, Affiliated to the Department of Hematology, San Bortolo Hospital, Vicenza
Haematologica Early view Jun 26, 2025 https://doi.org/10.3324/haematol.2025.287408

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2025.287408
 
Published
2025-06-26
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
216
PDF Downloads
105

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online